Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions

Ann Neurol. 2021 Jun;89(6):1255-1256. doi: 10.1002/ana.26054. Epub 2021 Mar 12.

Authors

Nicolas Lambert¹, Maximilien Steinmetz², Anne Sibille³, Bernard Sadzot¹

Affiliations

¹ Department of Neurology, University Hospital of Liège, Liège, Belgium.
² Department of Neurosurgery, University Hospital of Liège, Liège, Belgium.
³ Department of Pneumology, University Hospital of Liège, Liège, Belgium.

PMID: 33641185
DOI: 10.1002/ana.26054

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma of Lung / drug therapy
Antibodies, Monoclonal, Humanized / adverse effects*
Brain / drug effects*
Brain / pathology*
Encephalitis / chemically induced*
Encephalitis / pathology*
Humans
Lung Neoplasms / drug therapy
Male
Middle Aged

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab